Using bioinformatics and genome analysis for new therapeutic interventions

Molecular Cancer Therapeutics

Volumn 4, Issue 10, 2005, Pages 1636-1643

  Mount, David W ^a   Pandey, Ritu ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA; MESSENGER RNA; NEW DRUG; PROTEIN; TRANSCRIPTOME;

ALTERNATIVE RNA SPLICING; BIOINFORMATICS; BIOTECHNOLOGY; CANCER CELL; CANCER RESEARCH; DATA ANALYSIS; DNA MICROARRAY; DRUG DESIGN; DRUG TARGETING; GENE FUNCTION; GENETIC ALGORITHM; GENETIC VARIABILITY; GENOMICS; HUMAN; HUMAN GENOME; PRIORITY JOURNAL; PROTEIN FUNCTION; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENOME, HUMAN; GENOMICS; HUMANS; MICROARRAY ANALYSIS; NEOPLASMS;

EID: 27644582531     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-05-0150     Document Type: Short Survey

References (77)

1. Finishing the euchromatic sequence of the human genome. Nature 2004;431:931-45.
2. Pollack JR, Iyer VR. Characterizing the physical genome. Nat Genet 2002;32 Suppl:515-21.
3. Pollack JR, Perou CM, Alizadeh AA, et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 1999;23: 41-6.
4. Napoli C, Lemieux C, Jorgensen R. Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell 1990;2:279-89.
5. Hammond SM, Caudy AA, Hannon GJ. Post-transcriptional gene silencing by double-stranded RNA. Nat Rev Genet 2001;2:110-9.
6. Wolfsberg TG, Wetterstrand KA, Guyer MS, Collins FS, Baxevanis AD. A user's guide to the human genome. Nat Genet 2002;32 Suppl:1-79.
7. Baxevanis AD. Using genomic databases for sequence-based biological discovery. Mol Med 2003;9:185-92.
8. Baxevanis AD. The molecular biology database collection: 2003 update. Nucleic Acids Res 2003;31:1-12.
9. Galperin MY. The molecular biology database collection: 2005 update. Nucleic Acids Res 2005;33:D5-24.
10. Bailey JA, Gu Z, Clark RA, et al. Recent segmental duplications in the human genome. Science 2002;297:1003-7.
11. Boffelli D, McAuliffe J, Ovcharenko D, et al. Phylogenetic shadowing of primate sequences to find functional regions of the human genome. Science 2003;299:1391-4.
12. Sachidanandam R, Weissman D, Schmidt SC, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001;409:928-33.
13. Thorisson GA, Stein LD. The SNP Consortium website: past, present and future. Nucleic Acids Res 2003;31:124-7.
14. Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for Mendelian disease, future approaches for complex disease. Nat Genet 2003;33 Suppl:228-37.
15. Reich DE, Cargill M, Bolk S, et al. Linkage disequilibrium in the human genome. Nature 2001;411:199-204.
16. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-9.
17. Matise TC, Sachidanandam R, Clark AG, et al. A 3.9-centimorgan-resolution human single-nucleotide polymorphism linkage map and screening set. Am J Hum Genet 2003;73:271-84.
18. Matsuzaki H, Dong S, Loi H, et al. Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays. Nat Methods 2004;1:109-11.
19. Matsuzaki H, Loi H, Dong S, et al. Parallel genotyping of over 10,000 SNPs using a one-primer assay on a high-density oligonucleotide array. Genome Res 2004;14:414-25.
20. Tang K, Oeth P, Kammerer S, et al. Mining disease susceptibility genes through SNP analyses and expression profiling using MALDI-TOF mass spectrometry. J Proteome Res 2004;3:218-27.
21. Hein DW. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res 2002; 506-7:65-77.
22. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361:865-72.
23. Bafna V, Gusfield D, Hannenhalli S, Yooseph S. A note on efficient computation of haplotypes via perfect phylogeny. J Comput Biol 2004;11: 858-66.
24. Zhang K, Qin Z, Chen T, Liu JS, Waterman MS, Sun F. HapBlock: haplotype block partitioning and tag SNP selection software using a set of dynamic programming algorithms. Bioinformatics 2005;21:131-4.
25. Modrek B, Lee CJ. A genomic view of alternative splicing. Nat Genet 2002;30:13-9.
26. Modrek B, Lee CJ. Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of axon creation and/or loss. Nat Genet 2003;34:177-80.
27. Mercatante D, Kole R. Modification of alternative splicing pathways as a potential approach to chemotherapy. Pharmacol Ther 2000;85: 237-43.
28. Veuger MJ, Heemskerk MH, Honders MW, Willemze R, Barge RM. Functional role of alternatively spliced deoxycytidine kinase in sensitivity to cytarabine of acute myeloid leukemic cells. Blood 2002;99: 1373-80.
29. Bracco L, Kearsey J. The relevance of alternative RNA splicing to pharmacogenomics. Trends Biotechnol 2003;21:346-53.
30. Xu L, Hui L, Wang S, et al. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma. Cancer Res 2001;61:3176-81.
31. Lee C, Atanelov L, Modrek B, Xing Y. ASAP: the Alternative Splicing Annotation Project. Nucleic Acids Res 2003;31:101-5.
32. Lukashin AV, Fuchs R. Analysis of temporal gene expression profiles: clustering by simulated annealing and determining the optimal number of clusters. Bioinformatics 2001;17:405-14.
33. Iyer VR, Eisen MB, Ross DT, et al. The transcriptional program in the response of human fibroblasts to serum. Science 1999;283:83-7.
34. Hartigan J. Clustering algorithms. New York: John Wiley & Sons; 1975.
35. Jain AK, Dubes RC. Algorithms for clustering data. 1988.
36. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403: 503-11.
37. Dhanasekaran SM, Barrette TR, Ghosh D, et al. Delineation of prognostic biomarkers in prostate cancer. Nature 2001;412:822-6.
38. Vasselli JR, Shih JH, Iyengar SR, et al. Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor. Proc Natl Acad Sci U S A 2003;100:6958-63.
39. Yeung KY, Fraley C, Murua A, Raftery AE, Ruzzo WL. Model-based clustering and data transformations for gene expression data. Bioinformatics 2001;17:977-87.
40. McShane LM, Radmacher MD, Freidlin B, Yu R, Li MC, Simon R. Methods for assessing reproducibility of clustering patterns observed in analyses of microarray data. Bioinformatics 2002;18:1462-9.
41. Dudoit S, Fridlyand J. Bagging to improve the accuracy of a clustering procedure. Bioinformatics 2003;19:1090-9.
42. Hastie T, Tibshirani R, Eisen MB, et al. 'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns. Genome Biol 2000;1:RESEARCH0003; Epub 2000 Aug 4.
43. Sultan M, Wigle DA, Cumbaa CA, et al. Binary tree-structured vector quantization approach to clustering and visualizing microarray data. Bioinformatics 2002;18 Suppl 1:S111-9.
44. Bittner M, Meltzer P, Chen Y, et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000;406:536-40.
45. Mischel PS, Shai R, Shi T, et al. Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene 2003;22: 2361-73.
46. Kluger Y, Basri R, Chang JT, Gerstein M. Spectral biclustering of microarray data: coclustering genes and conditions. Genome Res 2003; 13:703-16.
47. Simon R, Radmacher MD, Dobbin K, McShane LM. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst 2003;95:14-8.
48. Dudoit S, Fridlyand J, Speed TP. Comparison of discrimination methods for the classification of tumors using gene expression data. J Am Stat Assoc 2002;97:77-87.
49. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999;286:531-7.
50. Shipp MA, Ross KN, Tamayo P, et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 2002;8:68-74.
51. Furey TS, Cristianini N, Duffy N, Bednarski DW, Schummer M, Haussler D. Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics 2000;16: 906-14.
52. Yeang CH, Ramaswamy S, Tamayo P, et al. Molecular classification of multiple tumor types. Bioinformatics 2001;17 Suppl 1:S316-22.
53. Ramaswamy S, Tamayo P, Rifkin R, et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A 2001; 98:15149-54.
54. Pomeroy SL, Tamayo P, Gaasenbeek M, et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002;415:436-42.
55. Nutt CL, Mani DR, Betensky RA, et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 2003;63:1602-7.
56. Khan J, Wei JS, Ringner M, et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 2001;7:673-9.
57. O'Neill MC, Song L. Neural network analysis of lymphoma microarray data: prognosis and diagnosis near-perfect. BMC Bioinformatics 2003;4:13.
58. Zhang H, Yu CY, Singer B, Xiong M. Recursive partitioning for tumor classification with gene expression microarray data. Proc Natl Acad Sci U S A 2001;98:6730-5.
59. Ooi CH, Tan P. Genetic algorithms applied to multi-class prediction for the analysis of gene expression data. Bioinformatics 2003;19:37-44.
60. Kim S, Dougherty ER, Barrera J, Chen Y, Bittner ML, Trent JM. Strong feature sets from small samples. J Comput Biol 2002;9:127-46.
61. Kim S, Dougherty ER, Shmulevich I, et al. Identification of combination gene sets for glioma classification. Mol Cancer Ther 2002; 1:1229-36.
62. Ambroise C, McLachlan GJ. Selection bias in gene extraction on the basis of microarray gene-expression data. Proc Natl Acad Sci U S A 2002; 99:6562-6.
63. Ben-Dor A, Bruhn L, Friedman N, Nachman I, Schummer M, Yakhini Z. Tissue classification with gene expression profiles. J Comput Biol 2000;7: 559-83.
64. Churchill GA. Fundamentals of experimental design for cDNA microarrays. Nat Genet 2002;32 Suppl:490-5.
65. Quackenbush J. Microarray data normalization and transformation. Nat Genet 2002;32 Suppl:496-501.
66. Simon R, Radmacher MD, Dobbin K. Design of studies using DNA microarrays. Genet Epidemiol 2002;23:21-36.
67. Cui X, Churchill GA. Statistical tests for differential expression in cDNA microarray experiments. Genome Biol 2003;4:210.
68. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004;3:Article 3.
69. Mount D. Bioinformatics: sequence and genome analysis. 2nd ed. New York, Cold Spring Harbor Laboratory Press; 2004.
70. Pandey R, Guru RK, Mount DW. Pathway Miner: extracting gene association networks from molecular pathways for predicting the biological significance of gene expression microarray data. Bioinformatics 2004;20:2156-8.
71. Butte AJ, Kohane IS. Mutual information relevance networks: functional genomic clustering using pairwise entropy measurements. Pac Symp Biocomput 2000;5:418-29.
72. Segal E, Wang H, Koller D. Discovering molecular pathways from protein interaction and gene expression data. Bioinformatics 2003;19 Suppl 1:1264-71.
73. Segal E, Yelensky R, Koller D. Genome-wide discovery of transcriptional modules from DNA sequence and gene expression. Bioinformatics 2003;19 Suppl 1:i273-82.
74. Pe'er D, Regev A, Elidan G, Friedman N. Inferring subnetworks from perturbed expression profiles. Bioinformatics 2001;17 Suppl 1: S215-24.
75. Hartemink AJ, Gifford DK, Jaakkola TS, Young RA. Combining location and expression data for principled discovery of genetic regulatory network models. Pac Symp Biocomput 2002;7:437-49.
76. Ideker T, Ozier O, Schwikowski B, Siegel AF. Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics 2002;18 Suppl 1:S233-40.
77. Shaaban S, Benton B. Orphan G protein-coupled receptors: from DNA to drug targets. Curr Opin Drug Discov Devel 2001;4:535-47.